Lung Cancers Today Videos

Marisa Bittoni, PhDLung Cancer | May 2, 2024
Dr. Marisa Bittoni discusses the possible link between vaping and lung cancer risk.
View More
Arun KrishnaNon-Small Cell Lung Cancer | April 4, 2024
Arun Krishna, of AstraZeneca, talks about the phase 3 FLAURA2 trial, which assessed Tagrisso in patients with NSCLC.
Marisa Bittoni, PhDLung Cancer | February 22, 2024
Marisa Bittoni, PhD, talks about a large-scale study exploring factors that lead to lung cancer in patients younger than 50.
Alexandra PotterLung Cancer | December 28, 2023
Alexandra Potter talks about health disparities that exist in lung cancer screening and treatment, and possible solutions.
Dr. Fred HirschLung Cancer | December 19, 2023
Dr. Fred Hirsch talks about recent trends in lung cancer that interest him.
Dr. Mona JhaveriLung Cancer | November 29, 2023
Dr. Mona S. Jhaveri discusses the importance of Lung Cancer Awareness Month, recent breakthroughs in lung cancer, and more.
Dr. Ofer SharonNon-Small Cell Lung Cancer | November 26, 2023
Dr. Ofer Sharon, CEO of OncoHost, to discusses a predictive biomarker for irAEs in non-small cell lung cancer.
Mark McDonoughNon-Small Cell Lung Cancer | November 22, 2023
Mark McDonough, CEO of ChromaCode, discusses an innovative, high-definition PCR assay for enhanced detection of NSCLC.
Rob DillardLung Cancer | November 13, 2023
Dr. Melissa Johnson, of Sarah Cannon, discusses lung cancer trials to keep an eye on and unmet needs in lung cancer.
Arun KrishnaNon-Small Cell Lung Cancer | November 9, 2023
Arun Krishna, of AstraZeneca, spoke about the FLAURA2 trial, which showed the efficacy of Tagrisso in the treatment of NSCLC.
Bo Wang, MDNon-Small Cell Lung Cancer | November 6, 2023
Drs. Bo Wang and Sheena Bhalla discuss the EVOKE-02 study, which assessed sacituzumab govitecan plus pembrolizumab in NSCLC.
Oncology BrothersOncology Brothers | November 8, 2023
Jill Feldman, a lung cancer survivor and co-founder of the EGFR Resisters advocacy group, details her lung cancer journey.
Oncology BrothersOncology Brothers | November 8, 2023
The Oncology Brothers discuss findings from the phase 3 ADAURA trial.
Dr. Patrick FordeASCO 2023 | September 21, 2023
Dr. Patrick Forde spoke with DocWire News at ASCO 2023 about updated data from the CheckMate 816 trial.
Oncology BrothersOncology Brothers | September 26, 2023
The Oncology Brothers highlight three studies from the recent American Association for Cancer Research (AACR) 2023 ...
Oncology BrothersOncology Brothers | September 26, 2023
In this episode, the Oncology Brothers speak with world-renowned thoracic oncologist Dr. Jarushka Naidoo of Royal ...
Oncology BrothersOncology Brothers | September 26, 2023
In this insightful episode, The Oncology Brothers are joined by Dr. Eric Singhi, Assistant Professor - University of ...
Oncology BrothersOncology Brothers | September 26, 2023
In this podcast episode, The Oncology Brothers are joined by Dr. Estelamari Rodriguez, University of Miami Health ...
Oncology BrothersOncology Brothers | September 26, 2023
The Oncology Brothers are joined by nationally renowned researcher and thoracic oncologist Charu Aggarwal, MD, MPH, of ...
Rob DillardLung Cancer | September 26, 2023
On Target Laboratories recently announced that the U.S. Food and Drug Administration (FDA) has cleared an expanded ...
Advertisement
Advertisement
Latest News

May 8, 2024